Since the commercialization of the first liposomes used for drug delivery, Doxil/Caelyx® and
Myocet®, tremendous progress has been made in understanding interactions between …

Since the early days marking the first use of nanomedicine in the early 80s, there has been a
meaningful change in the scientific field involving the Fabrication, characterization, and …

Targeting the immune system with nanomaterials is an intensely active area of research.
Specifically, the capability to induce immunosuppression is a promising complement for …

Immunomodulation is poised to revolutionize the treatment of cancer, autoimmune diseases,
and many other inflammation-related disorders. The immune system in these conditions can …

Research efforts on nanomaterial-based therapies for the treatment of autoimmune diseases
and cancer have spiked and have made rapid progress over the past years. Nanomedicine …

The exact role of engineered nanomaterials in immune system modulation remains unclear.
The aim of this concise review is to give a comprehensive insight into recent published …

This special issue “Nanomedicine and Cancer Immunotherapy” was organized for the
celebration of the 40th anniversary (1980–2020) of Acta Pharmacologica Sinica (APS). The …

Engineered nanomaterials hold promise for a wide range of applications in medicine.
However, safe use of nanomaterials requires that interactions with biological systems, not …

The potential for human exposure to the diverse and ever-changing world of nanoscale
materials has raised concerns about their influence on health and disease. The novel …

Immunotherapy has emerged as an effective strategy for the prevention and treatment of a
variety of diseases, including cancer, infectious diseases, inflammatory diseases, and …